Back to Journals » Psychology Research and Behavior Management » Volume 13

Quality of Life and Emotional States of Depression, Anxiety and Stress in Adolescents with Polycystic Ovary Syndrome: A Cross-Sectional Study

Authors Saei Ghare Naz M, Ramezani Tehrani F, Behroozi Lak T, Mohammadzadeh F, Nasiri M, Kholosi Badr F, Ozgoli G

Received 5 December 2019

Accepted for publication 12 February 2020

Published 28 February 2020 Volume 2020:13 Pages 203—209

DOI https://doi.org/10.2147/PRBM.S241192

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Mei-Chun Cheung



Marzieh Saei Ghare Naz,1,2 Fahimeh Ramezani Tehrani,2 Tahereh Behroozi Lak,3 Farnaz Mohammadzadeh,4 Malihe Nasiri,5 Farahnaz Kholosi Badr,6 Giti Ozgoli7

1Student Research Committee, Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 3Reproductive Health Research Center, Department of Infertility, Urmia University of Medical Sciences, Urmia, Iran; 4School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 5Department of Biostatistics, Faculty of Paramedic, Shahid Beheshti University of Medical Science, Tehran, Iran; 6Shahid Beheshti University of Medical Sciences, Tehran, Iran; 7Department of Midwifery and Reproductive Health, Midwifery and Reproductive Health Research Center, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Correspondence: Giti Ozgoli
Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Tel|Fax +98 21 88202512
Email [email protected]

Background: The chronic condition of polycystic ovary syndrome (PCOS) in adolescents can affect different aspects of quality of life in them. This study aimed to determine the correlation between the quality of life with emotional states of depression, anxiety, and stress in adolescents with PCOS.
Methods: This is a cross-sectional study conducted on 120 adolescents with PCOS in Tehran, Iran in 2019. The sociodemographic checklist, quality of life, depression, anxiety and stress (DASS) were assayed by valid and reliable questionnaires. The Pearson’s correlation coefficient and linear regression were used for data analysis, which was performed by SPSS (V.22).
Results: The mean (SD) age and menarche age of participants were 16.58 (1.36) and 12.52 (1.19) years, respectively. The most common clinical symptoms of adolescence were irregular menstruation (85%) and acne (61.7%). According to the result of this study, there was a significant reverse correlation between total score of SF-12 with total scores of depression, anxiety and stress (r=− 0.395, p=0.001) and a significant reverse correlation was also found between each dimension of DASS scale and 12-Item Short Form Survey (SF-12) (p< 0.001). Based on the linear regression model and after controlling the demographic variables, there was a linear regression relationship between total DASS score and SF-12 (Beta= − 0.367, p= 0.003).
Conclusion: The study results reveal the role of emotional states of depression, anxiety, and stress in the quality of life of adolescents with PCOS. Based on our findings, we emphasize the interventional studies and guides for improving all dimensions of quality of life and reducing the psychological burden of PCOS in later life of adolescence.

Keywords: polycystic ovary syndrome, quality of life, anxiety, depression, stress

Background

Polycystic ovary syndrome (PCOS) is a worldwide health problem in women of reproductive age.1,2 This multifaceted disorder may occur in 8–13% of the adolescences.3,4 Menstrual abnormality, acne and excess hair growth are the most frequent clinical symptoms of PCOS.5 The long-term sequelae of PCOS include type 2 diabetes, gynecological cancers, infertility and cardiovascular disease.6 There are different criteria for diagnosing PCOS in adolescence; however, it remains a challenging matter given the lack of consensus on diagnostic criteria among adolescents.7 The transition between childhood and adulthood named as adolescence phases, there are different definitions about the age of adolescence.8 In adolescence phases, the PCOS criteria overlap with normal pubertal development.9 So, the diagnosis of PCOS in adolescents is difficult than adults.10

Self-image is an important factor in the perception of quality of life among adolescents.11 Women with PCOS have poorer self-esteem and self-image satisfaction because of clinical symptoms such as menstrual irregularities and hirsutism.12 The quality of life is an essential outcome in chronic diseases,13 which means the “goodness” of different aspects from everyone’s life.14 Women with PCOS may experience a lower health-related quality of life.15 Several pieces of evidence suggest the increase of psychological disorders in PCOS females.16 Females with PCOS may be afflicted with psychiatric disorders or psychosocial concerns.17 Several studies have reported psychotic disorders in female adults and adolescents who suffer from PCOS.18,19

Since more than half of mental disorders in adult period originate from adolescence,20 it seems that the prevention and early detection of these disorders in adolescence are of high importance. Recently, there have been investigations about quality of life and mental disorders in adult women with PCOS, but there is scarce scientific literature about the relationship between quality of life and psychological aspects in adolescents with PCOS. On the other hand, it appears that different health aspects of adolescence with PCOS differ from adult women with PCOS. Therefore, this study aimed to investigate the following items:

  1. Determine the correlation between depression, anxiety and stress with quality of life in adolescents with PCOS and
  2. Discover the relationship between PCOS symptom with depression, anxiety and stress in adolescents with PCOS

This study provides useful information for promoting the health and well-being of adolescents with PCOS.

Methods

This cross-sectional study was conducted in health centers affiliated with Shahid Beheshti University of medical sciences in 2019. The study protocol was approved by the Research and Ethics Committee of Shahid Beheshti University of Medical Sciences, Tehran, Iran [IR.SBMU.RETECH.REC.1397.904]. The sample size of the study was calculated based on the following formula presented by Milsom et al study:21

Based on the above formula, the sample size was estimated 112; however, after considering the non-responding subjects, the final sample size was 120 adolescents aged 13–19 years.

Study Population

The inclusion criteria of the study were as follows: female school-going adolescent (aged 13–19 years), polycystic ovary syndrome diagnosed by gynecologist based on Rotterdam criteria (oligoovulation and/or anovulation, hyperandrogenism, polycystic ovaries22), no history of chronic disease, voluntary participation in the study. The exclusion criteria were participants with previous mental illness through self-report on history, psychiatric diagnoses, consumption of psychiatric medications and having diseases, such as non-classic congenital adrenal hyperplasia, thyroid dysfunction, hyperprolactinemia, etc., based on international evidence-based guideline.23 The participants were recruited from health centers and gynecological clinics of Shahid Beheshti University of medical sciences and those who did not consent to take part in this study were excluded. In this study after explanation, the objectives of study the written informed consent obtained from the adolescents and their parent or legal guardian. The participants over the age of 18 years provided written informed consent, and that this study was conducted in accordance with the Declaration of Helsinki.

Assessment

The assessment questionnaire included the following items:

  1. A checklist related to demographic features and medical history (age, weight, height, body mass index, menarche age, menstrual regularity, parent education, family income, place of living, and medical history), and the data were collected by the recall and interview with adolescence and their parents.
  2. Depression Anxiety Stress Scales-21 (DASS-21). This tool is a self-report scale with three domains (depression, anxiety, stress), each of which includes 7 items.24 DASS-21 was scored based on 4-point Likert scale (0–3). The final score of each domain (depression, anxiety, and stress) was multiplied by 2. The range of stress domain was normal: 0–10, mild: 11–18, moderate: 19–26, severe: 27–34, and extremely severe: 35–42). The range of anxiety domain was as follows: normal: 0–6, mild: 7–9, moderate: 10–14, severe: 15–19, extremely severe: 20–42) and the range of depression domain was normal: 0–9, mild: 10–12, moderate: 13–20, severe: 21–27, and extremely severe: 28–42). The total score of DASS was calculated by summing up the items of each domain. Asghari et al study confirmed the validity and reliability of the Persian version of Depression Anxiety Stress Scales-21 (DASS-21) in Iranian people.25 In our study, the test re-test was done on 10 adolescents with PCOS.
  3. Twelve-item Short-Form Health Survey (SF-12): This short-form scale provides us with summary information on the status of mental and physical health of each person.26 It measures the physical health-related domains such as General Health (GH), Physical Functioning (PF), Role Physical (RP), and Body Pain (BP). Mental health-related scales include Vitality (VT), Social Functioning (SF), Role Emotional (RE) and Mental Health (MH). Montazeri et al confirmed the validity and reliability of the Persian version of the 12-item Short-Form Health Survey among the Iranian population.27 In this scale, the 37–48 score range demonstrates a good quality of life; 25–36 shows a moderate quality of life; and 12–24 a poor quality of life.

Statistical Analysis

The analysis of data was performed in IBM SPSS version 17. The quantitative variables were described with a mean (SD) and qualitative variables were defined by frequency (%). Kolmogorov–Smirnov test was used for evaluating the normality of variables. Pearson’s correlation coefficient was employed to calculate the correlation between DASS score and SF-12 score. In the linear regression model, SF-12 was the dependent factor and DASS and sociodemographic factors were considered as intended factors. The significance level was considered to be less than 0.05.

Results

One hundred and twenty adolescents aged 13–19 years with PCOS participated in this study. The mean age and menarche age of participants were 16.58 and 12.52 years, respectively. Table 1 shows the demographic characteristics of the participants. The mean (SD) of total DASS score was 44.2 (21.4), the depression 12.88 (9.15), anxiety 12.73 (7.92), and the stress 18.58 (8.72) with total SF-12 score of 33.68 (4.71).

Table 1 Demographic Characteristics of Study Participants

The most common clinical symptom of adolescence was irregular menstruation (85%) and the most frequent complaint site of acne was the right cheek (44.8%). The characteristics of clinical symptoms are indicated in Table 2. According to the results of this study, there was a significant reverse correlation between total score of SF-12 with total score of depression, anxiety and stress (r= –0.395, p=0.001) and a significant reverse correlation was found between each dimension of DASS scale and SF-12 (p<0.001). (Table 3). In this research, there was no significant difference between PCOS symptoms with depression, anxiety and stress (p>0.05).

Table 2 The Frequency of Clinical Symptoms in Participants

Table 3 Pearson Correlation Coefficient Matrix of the Measured Variables

According to the linear regression model, after controlling for demographic variables, there was a linear regression relationship between total DASS score and SF-12 (Beta=−0.367, p=0.003) (Table 4).

Table 4 The Linear Regression Model of Quality of Life

Discussion

In this study, we assessed the relationship between quality of life with emotional states of depression, anxiety, and stress in adolescents with polycystic ovary syndrome.

Our research demonstrates that 85% of the adolescents experience irregular menstrual cycle, 61.7% have acne and 59% suffer from hair loss. Interestingly, in this study, there was no significant difference between PCOS symptoms with depression, anxiety and stress.

Nevertheless, the result of a study on adult Iranian women with PCOS showed a significant relationship between PCOS symptom and depression.28 It seems that the physiological changes due to puberty overlap with PCOS symptoms during adolescence period;29 therefore, a number of symptoms attributed to PCOS may be a function of the normal process of puberty. In this regard, Rahebi et al (2015) reported that the age is a predictor of depression in women with PCOS.30 On the other hand, in adults with PCOS, the infertility and stress of future life without a child are a psychological factor menacing their health.31 Barry et al (2011) in a meta-analysis revealed that women with PCOS reported higher depression and anxiety scores.32 The result of the Australian Longitudinal Study of Women’s Health showed that the prevalence of mental health problems (ie, depression, anxiety and stress) was higher in women with PCOS than those without it.33 It appears that the parents and health-care providers should provide more emotional and social support for the adolescents with PCOS because of psychological aspects of this disease.

According to the findings of this study, there was a significant reverse correlation between the total score of SF-12 and that of depression, anxiety and stress score. The correlation between quality of life with depression, anxiety and stress has been reported in previous studies in adult women with PCOS. Likewise, Chaudhari et al (2018) reported that women aged 18–45 years with PCOS experience 38% anxiety and 25% depression and that these psychological factors have a negative correlation with the quality of life.34 Consistent with our study, Trent et al (2001) research on adolescents aged 13–22 years showed that PCOS negatively affected quality of life of adolescents.35 Nevertheless, the result of a study on 28 Turkish adolescents with PCOS and 31 healthy peers indicated that the Pediatric Quality of Life Inventory score was not significant between the two groups.36 Surprisingly, the findings of a pilot study on 37 adolescents with PCOS revealed that there is no significant correlation between anxiety and depressive state in both groups of adolescents with and without PCOS.19 In Yoldemir et al (2017) study, menstrual problems were the worst factor affecting the quality of life in women with PCOS.37 The experience of PCOS women reveals that the discomfort related to menstrual abnormality should be considered as a part of patient-reported outcome measures.38 Depression in adolescence period is a threat throughout the developmental phases of adolescence life.39 Chronic disorders in adolescence can disrupt the quality of life aspects, which involves them with different concerns and challenges.40 The health-related quality of life is affected by psychological and physical health factors.20 It seems that the quality of life of adolescents with PCOS in our study was influenced by various psychological and physical health factors.

Difficulty in the diagnosis of PCOS in adolescence and lack of agreement on diagnosis criteria41 that lead to delayed diagnosis of PCOS cause dissatisfaction in patients.42 It appears that late diagnosis and facing with different challenges of PCOS symptoms can threaten the quality of life and mental health of females.

Finally, the current findings suggested the need for a comprehensive assessment of quality of life in adolescents with a disease-specific questionnaire. Based on our findings, we emphasize the interventional studies and guidelines for improving all dimensions of quality of life and reducing the psychological burden of PCOS in later life of adolescents. Investment on adolescent health can guarantee their future life as well as public health.

The symptoms of PCOS may affect the physiological aspects of adolescents afflicted with PCOS, after which different aspects of quality of life are influenced. An implication of the findings of this study is to regard psychological and mental issues as well as emotional support of adolescents with polycystic ovary syndrome and training their parents to help them. Based on the International evidence-based guideline for the assessment and management of PCOS (2018) should be screened for depressive and anxiety symptoms.23 It is likewise essential to plan psychological consultation of adolescences, especially in coping with PCOS.

Limitation

Because of cross-sectional design of our study, it was not possible to estimate the causal relationship between depression, anxiety and stress with SF-12 form. Previous studies have used different instruments for assessing the relationship between quality of life and its aspects43 with depression, anxiety and stress, which is a limitation restricting the comparison of our findings with previous studies. Moreover, given the lack of a disease-specific questionnaire about PCOS in adolescents, we suggest future studies about disease-specific quality of life questionnaires in adolescents with PCOS.

Conclusion

These study results reveal the role of emotional states of depression, anxiety, and stress in the quality of life of adolescents with PCOS. Based on our findings, we emphasize the interventional research and directives for improving all dimensions of quality of life and diminishing the psychological burden of PCOS in later life of adolescents.

Abbreviations

PCOS, polycystic ovary syndrome; DASS, depression, anxiety and stress; SF-12: 12-Item Short Form Survey (SF-12).

Acknowledgments

This study is related to the  project NO. 1397/69611 From Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran. We also appreciate the “Student Research Committee” and “Research & Technology Chancellor” in Shahid Beheshti University of Medical Sciences for their financial support of this study.

Disclosure

The authors report no conflicts of interest in this study.

References

1. Ding T, Hardiman PJ, Petersen I, Wang -F-F, Qu F, Baio G. The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis. Oncotarget. 2017;8(56):96351. doi:10.18632/oncotarget.19180

2. Wolf W, Wattick R, Kinkade O, Olfert M. Geographical prevalence of polycystic ovary syndrome as determined by region and race/ethnicity. Int J Environ Res Public Health. 2018;15(11):2589. doi:10.3390/ijerph15112589

3. Desai N, Tiwari R, Patel S. Prevalence of polycystic ovary syndrome and its associated risk factors among adolescent and young girls in Ahmedabad region. Indian J Pharm Pract. 2018;11(3):119. doi:10.5530/ijopp.11.3.27

4. Esmaeilzadeh S, Delavar MA, Amiri M, Khafri S, Pasha NG. Polycystic ovary syndrome in Iranian adolescents. Int J Adolesc Med Health. 2014;26(4):559–565. doi:10.18203/2320-1770.ijrcog20193784

5. Rosenfield RL. The diagnosis of polycystic ovary syndrome in adolescents. Pediatrics. 2015;136(6):1154–1165. doi:10.1542/peds.2015-1430

6. Barthelmess EK, Naz RK. Polycystic ovary syndrome: current status and future perspective. Front Biosci (Elite Ed). 2014;6:104. doi:10.2741/e695

7. Tehrani FR, Amiri M. Polycystic ovary syndrome in adolescents: challenges in diagnosis and treatment. Int J Endocrinol Metab. 2019;17(3):e91554.

8. Sawyer SM, Azzopardi PS, Wickremarathne D, Patton GC. The age of adolescence. Lancet Child Adolesc Health. 2018;2(3):223–228. doi:10.1016/S2352-4642(18)30022-1

9. Witchel SF, Oberfield S, Rosenfield RL, et al. The diagnosis of polycystic ovary syndrome during adolescence. Horm Res Paediatr. 2015;83(6):376–389. doi:10.1159/000375530

10. Deans R. Polycystic ovary syndrome in adolescence. Med Sci. 2019;7(10):101. doi:10.3390/medsci7100101

11. Helseth S, Misvær N. Adolescents’ perceptions of quality of life: what it is and what matters. J Clin Nurs. 2010;19(9–10):1454–1461. doi:10.1111/j.1365-2702.2009.03069.x

12. Bazarganipour F, Ziaei S, Montazeri A, Foroozanfard F, Kazemnejad A, Faghihzadeh S. Body image satisfaction and self-esteem status among the patients with polycystic ovary syndrome. Iran J Reprod Med. 2013;11(10):829.

13. Megari K. Quality of Life in chronic disease patients. Health Psychol Res. 2013;1(3):e27. doi:10.4081/hpr.2013.e27

14. Theofilou P. Quality of life: definition and measurement. Eur J Psychol. 2013;9(1):150–162. doi:10.5964/ejop.v9i1.337g

15. Li Y, Li Y, Ng EHY, et al. Polycystic ovary syndrome is associated with negatively variable impacts on domains of health-related quality of life: evidence from a meta-analysis. Fertil Steril. 2011;96(2):452–458. doi:10.1016/j.fertnstert.2011.05.072

16. Sulaiman MA, Al-Farsi YM, Al-Khaduri MM, Waly MI, Saleh J, Al-Adawi S. Psychological burden among women with polycystic ovarian syndrome in Oman: a case-control study. Int J Womens Health. 2017;9:897–904. doi:10.2147/IJWH.S145383

17. Azizi M, Elyasi F. Psychosomatic aspects of polycystic ovarian syndrome: a review. Iran J Psychiatry Behav Sci. 2017;11:2. doi:10.5812/ijpbs.6595

18. Sadeeqa S, Mustafa T, Latif S. Polycystic ovarian syndrome-related depression in adolescent girls: a review. J Pharm Bioallied Sci. 2018;10(2):55–59. doi:10.4103/JPBS.JPBS_1_18

19. Ghazeeri G, Fakih A, Abbas HA, Harajly S, Awwad J. Anxiety, cognitive, and depressive assessment in adolescents with polycystic ovarian syndrome: a pilot study. J Pediatr Adolesc Gynecol. 2013;26(5):269–273. doi:10.1016/j.jpag.2013.04.005

20. Kessler RC, Angermeyer M, Anthony JC, et al. Lifetime prevalence and age-of-onset distributions of mental disorders in the world health organization’s world mental health survey initiative. World Psychiatry. 2007;6(3):168–176.

21. Milsom SR, Nair SM, Ogilvie CM, Stewart JM, Merry SN. Polycystic ovary syndrome and depression in New Zealand adolescents. J Pediatr Adolesc Gynecol. 2013;26(3):142–147. doi:10.1016/j.jpag.2012.11.013

22. Azziz R. Diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab. 2006;91(3):781–785. doi:10.1210/jc.2005-2153

23. Teede H, Misso M, Costello M, et al. International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2018. Melbourne, Australia: Monash University; 2018.

24. Henry JD, Crawford JR. The short‐form version of the Depression Anxiety Stress Scales (DASS‐21): construct validity and normative data in a large non‐clinical sample. Br J Clin Psychol. 2005;44(2):227–239. doi:10.1348/014466505X29657

25. Asghari A, Saed F, Dibajnia P. Psychometric properties of the Depression Anxiety Stress Scales-21 (DASS-21) in a non-clinical Iranian sample. Int J Psychol. 2008;2(2):82–102.

26. Jenkinson C, Layte R. Development and testing of the UK SF-12. J Health Serv Res Policy. 1997;2(1):14–18. doi:10.1177/135581969700200105

27. Montazeri A, Vahdaninia M, Mousavi SJ, Omidvari S. The Iranian version of 12-item Short Form Health Survey (SF-12): factor structure, internal consistency and construct validity. BMC Public Health. 2009;9(1):341. doi:10.1186/1471-2458-9-341

28. Bazarganipour F, Ziaei S, Montazeri A, Foroozanfard F, Kazemnejad A, Faghihzadeh S. Psychological investigation in patients with polycystic ovary syndrome. Health Qual Life Outcomes. 2013;11(1):141. doi:10.1186/1477-7525-11-141

29. Spritzer P, Motta A. Adolescence and polycystic ovary syndrome: current concepts on diagnosis and treatment. Int J Clin Pract. 2015;69(11):1236–1246. doi:10.1111/ijcp.12719

30. Rahebi SM, Ghanbari A, Soltani PR, et al. Depression in women with polycystic ovary syndrome: the role of body mass index and infertility on it. Nurs Pract Today. 2015;2(4):152–157.

31. Basirat Z, Faramarzi M, Esmaelzadeh S, Firoozjai SA, Mahouti T, Geraili Z. Stress, depression, sexual function, and alexithymia in infertile females with and without polycystic ovary syndrome: a case-control study. Int J Fertil Steril. 2019;13(3):203. doi:10.22074/ijfs.2019.5703

32. Barry JA, Kuczmierczyk AR, Hardiman PJ. Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2011;26(9):2442–2451. doi:10.1093/humrep/der197

33. Damone AL, Joham AE, Loxton D, Earnest A, Teede HJ, Moran LJ. Depression, anxiety and perceived stress in women with and without PCOS: a community-based study. Psychol Med. 2019;49(9):1510–1520. doi:10.1017/S0033291718002076

34. Prathap A, Subhalakshmi TP, Varghese PJ. A cross-sectional study on the proportion of anxiety and depression and determinants of quality of life in polycystic ovarian disease. Indian J Psychol Med. 2018;40(3):257–262. doi:10.4103/IJPSYM.IJPSYM_221_17

35. Trent ME, Rich M, Austin SB, Gordon CM. Quality of life in adolescent girls with polycystic ovary syndrome. Arch Pediatr Adolesc Med. 2002;156(6):556–560. doi:10.1001/archpedi.156.6.556

36. Çoban ÖG, Tulacı ÖD, Adanır AS, Önder A. Psychiatric disorders, self-esteem, and quality of life in adolescents with polycystic ovary syndrome. J Pediatr Adolesc Gynecol. 2019;32(6):600–604. doi:10.1016/j.jpag.2019.07.008

37. Yoldemir T, Angin P, Ramoglu S, Atasayan K. Health-related quality of life (HRQL) in women with polycystic ovary syndrome (PCOS). Maturitas. 2017;100:175. doi:10.1016/j.maturitas.2017.03.192

38. Martin ML, Halling K, Eek D, Krohe M, Paty J. Understanding polycystic ovary syndrome from the patient perspective: a concept elicitation patient interview study. Health Qual Life Outcomes. 2017;15(1):162. doi:10.1186/s12955-017-0736-3

39. Clayborne ZM, Varin M, Colman I. Systematic review and meta-analysis: adolescent depression and long-term psychosocial outcomes. J Am Acad Child Adolesc Psychiatry. 2019;58(1):72–79. doi:10.1016/j.jaac.2018.07.896

40. Santos T, Matos M, Marques A, Simões C, Leal I, Machado M. Psychosocial profile in portuguese adolescents with chronic disease attending an outpatient department in a hospital setting. Int J Pediatr. 2018;2018:1–10. doi:10.1155/2018/9382648

41. Carmina E, Oberfield SE, Lobo RA. The diagnosis of polycystic ovary syndrome in adolescents. Am J Obstet Gynecol. 2010;203(3):201.e1-. e5. doi:10.1016/j.ajog.2010.03.008

42. Gibson-Helm M, Teede H, Dunaif A, Dokras A. Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2017;102(2):604–612. doi:10.1210/jc.2016-2963

43. Moghadam ZB, Fereidooni B, Saffari M, Montazeri A. Measures of health-related quality of life in PCOS women: a systematic review. Int J Womens Health. 2018;10:397–408. doi:10.2147/IJWH.S165794

Creative Commons License © 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.